About Event
The Only Forum That Offers LNP-Specific Networking, Partnership Opportunities & Collaborative Discussions
Curated in collaboration with our Scientific Advisory Board, Annette Bak (AstraZeneca), Pieter Cullis (University of British Columbia), Sanya Puri (Novo Nordisk) and Magali Hickey (Moderna), the 4th LNP Formulation & Process Development Summit returns with three jam-packed days and unrivalled networking opportunities with key stakeholders to accelerate discovery of novel ionizable lipids, improve LNP safety and optimize manufacturing scale-up for more successful advancements of LNPs towards the market.
50+ LNP experts will navigate through presentations, interactive discussions and deep-dive workshops to provide you with an end-to-end roadmap for developing LNP-mediated therapeutics and vaccines.
Here’s a Snapshot of the Unmissable Sessions
INDUSTRY LEADERS’ PANEL DISCUSSION: Navigate challenges of toxicity, extrahepatic delivery and scaling up to accelerate your LNP pipelines by acquiring first-hand insights from Pieter Cullis, Alnylam, AstraZeneca, Moderna & Novo Nordisk
LNPS FOR CELL & GENE THERAPY DELIVERY: Uncover the potential of LNPs for delivering payloads beyond mRNA and hear brand-new insights from Bristol Myers Squibb, Prime Medicine, Carisma Therapeutics & Yoltech Therapeutics to enhance the delivery of cell therapy and gene editing payloads
ESTABLISH A RELIABLE & SUCCESSFUL LNP TOOLKIT: Explore the core principles of effective LNP development at LNP 101 Day, featuring insights from Takeda, Tessera Therapeutics, and Strand Therapeutics. Gain practical knowledge for leveraging LNPs as a powerful delivery vehicle.
MITIGATE LNP PATENT RISKS: During an interactive, deep-dive workshop led by Rothwell Figg, de-risk patent infringements by leveraging robust due diligence and freedom-to-operate strategies to ensure strong and compliant IP for your LNP vehicles
THE FUTURE OF LNPS: Advance nucleic acid delivery with next-generation LNPs! Hear from Entos Pharmaceuticals and Zipcode Bio as they unveil the newest and most innovative LNP delivery vehicles, enabling tissue-specific delivery of payloads to the liver and beyond.
Previously Attending Companies Include:
